Author | Ahmet Dogan, MD, PhD | OncLive

Author | Ahmet Dogan, MD, PhD


Dr. Dogan on Updated WHO Classifications in DLBCL

March 30, 2017


Ahmet Dogan, MD, PhD, chief of Hematopathology Service, Departments of Pathology and Laboratory Medicine at Memorial Sloan Kettering Cancer Center, discusses the updated World Health Organization (WHO) classification and how it impacts treatment decisions for patients with diffuse large B-cell lymphoma (DLBCL).